Transglutaminase 2 (TG2) is a very multifunctional protein that is ubiquitously expressed in the body. It is a Ca 2+ -dependent transamidating enzyme, a GTPase, as well as a scaffolding protein. TG2 is the predominant form of transglutaminase expressed in the mammalian nervous system. Previously, it was shown that TG2 can affect both cell death and cell survival mechanisms depending on the cell type and the stressor. In the case of ischemic stress, TG2 was previously shown to play a protective role in the models used. For example in hTG2 transgenic mice, where TG2 is overexpressed only in neurons, middle cerebral artery ligation (MCAL) resulted in smaller infarct volumes compared to wild type mice. In this study TG2 knock out mice were used to determine how endogenous TG2 affected stroke volumes. Intriguingly, infarct volumes in TG2 knock out mice were significantly smaller compared to wild type mice. As expected, primary neurons isolated from TG2 knock out mice showed decreased viability in response to oxygen-glucose deprivation. However, primary astrocytes that were isolated from TG2 knock out mice were resistant to oxygen-glucose deprivation in situ. Both wild type and knock out neurons were protected against oxygen glucose deprivation when they were co-cultured with astrocytes from TG2 knockout mice. Therefore, the decreased stroke volumes observed in TG2 knock out mice after MCAL, can be correlated with the protective effects of TG2 knock out in astrocytes in response to oxygen glucose deprivation in situ. These findings suggest that neuron-astrocyte crosstalk plays a significant role in mediating ischemic cell death and that TG2 differentially impacts cell survival depending on cell context.
Introduction
Stroke remains as a leading cause of death in the United States in part due to the lack of effective therapeutics for most patients (Cramer, 2011) . The complexity of intracellular signaling mechanisms that are triggered in an ischemic event, as well as the variety of cell types that are affected in the brain, have made the search for effective treatments a daunting task. However it is becoming increasingly evident that subsequent to stroke the coordinated response of all the cells in the brain, including neurons, glia and vascular endothelial cells, plays a significant role in the final outcome (Yenari and Lee, 2011) . Therefore it is critically important to understand how each cell type responds to ischemic stress and in turn how this impacts the survival of the other cells in the affected area of the brain.
Neuron-astrocyte interactions are especially important when it comes to neurodegenerative pathologies, as astrocytes have many functions that support the viability of neurons such as buffering the extracellular space, providing substrates to neurons and interchanging glutamate for glutamine (Verkhratsky and Toescu, 2006) . Neurons and astrocytes respond differently to ischemic stress, in part due to differences in their cellular metabolism. Astrocytes are more dependent on glycolytic metabolism and they possess glycogen stores which makes them less susceptible to ischemia. In contrast, neurons are highly dependent on oxidative metabolism and thus are more sensitive to oxygen-glucose deprivation (Escartin et al., 2006) . The support of neurons by astrocytes is very important in ischemic conditions. Deficits in astrocytes function can negatively impact stroke size and recovery. If the astrocytic functions such as extracellular buffering or glutamate uptake are compromised, infarct size might increase due to an increase loss of neurons (Rossi et al., 2007) . Additionally, astrocytes express neuroprotective factors such as erythropoietin (EPO) (Diaz et al., 2005; Liu et al., 2006) , vascular endothelial growth factor (VEGF) (Rosenstein and Krum, 2004) and adenosine (Hamilton and Abbreviations: TG2, transglutaminase 2; MCAL, middle cerebral artery ligation; OGD, oxygen-glucose deprivation; TG2 −/− , TG2 knock out; hTG2, human TG2; EPO, erythropoietin; VEGF, vascular endothelial growth factor; MMP-9, matrix metalloproteinase-9; NF-кB, nuclear factor kappa B; TTC, triphenyltetrazolium chloride; IL-1β, interleukin 1β. 
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